Logotipo del repositorio
Logotipo del repositorio
 

Prevalence and target attainment of traditional cardiovascular risk factors in patients with systemic lupus erythematosus: a cross-sectional study including 3401 individuals from 24 countries

Vista sencilla de ítem
datacite.rightshttp://purl.org/coar/access_right/c_abf2
dc.contributor.authorBolla, Eleana
dc.contributor.authorGrete Semb, Anne
dc.contributor.authorKerola, Anne M
dc.contributor.authorIkdahl, Eirik
dc.contributor.authorPetri, Michelle
dc.contributor.authorPons-Estel, Guillermo J
dc.contributor.authorGeorge A, Karpouzas
dc.contributor.authorSfikakis, Petros P
dc.contributor.authorQuintana, Rosana
dc.contributor.authorPrasanna Misra, Durga
dc.contributor.authorEduardo, Ferreira Borba
dc.contributor.authorGarcia-de la Torre, Ignacio
dc.contributor.authorPopkova, Tatiana V
dc.contributor.authorArtim-Esen, Bahar
dc.contributor.authorTroldborg, Anne
dc.contributor.authorFragoso-Loyo, Hilda
dc.contributor.authorAjeganova, Sofia
dc.contributor.authorYazici, Ayten
dc.contributor.authorAroca-Martinez, Gustavo
dc.contributor.authorDireskeneli, Haner
dc.contributor.authorZucchi, Dina
dc.date.accessioned2024-06-13T22:38:49Z
dc.date.available2024-06-13T22:38:49Z
dc.date.issued2024
dc.description.abstractSystemic lupus erythematosus (SLE) is a complex systemic autoimmune disorder affecting mostly young women. Patients with SLE have a two-to-ten-fold higher risk for cardiovascular events compared with the general population,1 and cardiovascular disease, along with infections, represents a leading cause of mortality in these patients.2 Several disease-related risk factors have been associated with high risk of cardiovascular disease in SLE, including disease duration and activity, renal involvement, treatment-associated factors (eg, prolonged exposure to glucocorticoids), and antiphospholipid antibodies.3 The presence of persistently positive antiphospholipid antibodies in association with arterial or venous thrombosis, characterised as antiphospholipid syndrome, has been linked to high cardiovascular-related morbidity risk in patients with SLE.4 Increasing evidence has also shown an independent association between traditional cardiovascular risk factors and cardiovascular events in patients with SLE. The 2022 European Alliance of Associations for Rheumatology (EULAR) recommendations for the management of cardiovascular risk in rheumatic and musculoskeletal diseases including SLE and antiphospholipid syndrome, highlighted the importance strict control of traditional cardiovascular risk factors in these patients.5 For the management of most traditional cardiovascular risk factors in SLE, the implementation of the established guidelines for the general population was recommended, emphasising also the importance of a blood pressure target of lower than 130/80 mm Hg.5 However, reports originating mostly from single-centre studies, have shown that cardiovascular risk factors are often unrecognised and undertreated in patients with SLE.6eng
dc.format.mimetypepdf
dc.identifier.doihttps://doi.org/10.1016/S2665-9913(24)00090-0
dc.identifier.issn26659913 (Online)
dc.identifier.urihttps://hdl.handle.net/20.500.12442/14733
dc.identifier.urlhttps://www.sciencedirect.com/science/article/abs/pii/S2665991324000900
dc.language.isoeng
dc.publisherElsevier
dc.rightsAttribution-NonCommercial-NoDerivs 3.0 United Stateseng
dc.rights.accessrightsinfo:eu-repo/semantics/closedAccess
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/3.0/us/
dc.sourceThe Lancet Rheumatology
dc.titlePrevalence and target attainment of traditional cardiovascular risk factors in patients with systemic lupus erythematosus: a cross-sectional study including 3401 individuals from 24 countrieseng
dc.type.driverinfo:eu-repo/semantics/article
dc.type.spaArtículo científico
dcterms.referencesSR Schoenfeld et al. The epidemiology of atherosclerotic cardiovascular disease among patients with SLE: a systematic review Semin Arthritis Rheum (2013)eng
dcterms.referencesS Miyakis et al. International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS) J Thromb Haemost (2006)eng
dcterms.referencesGR Dagenais et al. Variations in common diseases, hospital admissions, and deaths in middle-aged adults in 21 countries from five continents (PURE): a prospective cohort study Lancet (2020)eng
dcterms.referencesSM Grundy et al. AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA guideline on the management of blood cholesterol: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines J Am Coll Cardiol (2019)eng
dcterms.referencesHH Yu et al. Statin reduces mortality and morbidity in systemic lupus erythematosus patients with hyperlipidemia: a nationwide population-based cohort study Atherosclerosis (2015)eng
dcterms.referencesMG Tektonidou Cardiovascular disease risk in antiphospholipid syndrome: thrombo-inflammation and atherothrombosis J Autoimmun (2022)eng
dcterms.referencesJ Yazdany et al. Systemic lupus erythematosus; stroke and myocardial infarction risk: a systematic review and meta-analysis RMD Open (2020)eng
dcterms.referencesMG Tektonidou et al. Survival in adults and children with systemic lupus erythematosus: a systematic review and Bayesian meta-analysis of studies from 1950 to 2016 Ann Rheum Dis (2017)eng
dcterms.referencesN Farina et al. Antiphospholipid antibody positivity in early systemic lupus erythematosus is associated with subsequent vascular events Rheumatology (2023)eng
dcterms.referencesGC Drosos et al. EULAR recommendations for cardiovascular risk management in rheumatic and musculoskeletal diseases, including systemic lupus erythematosus and antiphospholipid syndrome Ann Rheum Dis (2022)eng
dcterms.referencesN Papazoglou et al. The impact of traditional cardiovascular risk factor control on 7-year follow-up atherosclerosis progression in systemic lupus erythematosus Rheumatology (2024)eng
dcterms.referencesCK Chow et al. Prevalence, awareness, treatment, and control of hypertension in rural and urban communities in high-, middle-, and low-income countries JAMA (2013)eng
dcterms.referencesJW Maynard et al. Low socioeconomic status is associated with cardiovascular risk factors and outcomes in systemic lupus erythematosus J Rheumatol (2012)eng
dcterms.referencesS Rollefstad et al. An international audit of the management of dyslipidaemia and hypertension in patients with rheumatoid arthritis: results from 19 countries Eur Heart J Cardiovasc Pharmacother (2022)eng
dcterms.referencesM Petri et al. Derivation and validation of the Systemic Lupus International Collaborating Clinics classification criteria for systemic lupus erythematosus Arthritis Rheum (2012)eng
oaire.versioninfo:eu-repo/semantics/publishedVersion

Archivos

Bloque de licencias
Mostrando 1 - 1 de 1
No hay miniatura disponible
Nombre:
license.txt
Tamaño:
381 B
Formato:
Item-specific license agreed upon to submission
Descripción:
Descargar

Colecciones

Artículos

Universidad Simón Bolívar: Todos los derechos reservados / Sistema de biblioteca